Our circular RNA (circRNA) biomarker programs deliver precision tools for urgent neurological and psychiatric needs. We aim to develop a suite of tests that can address some of the world’s largest health problems in psychiatry and neurology through our unique and powerful circRNA-enabled tools. Led by MindLight™ for predicting antidepressant response, we are also advancing programs in Alzheimer’s disease, bipolar disorder, and Parkinson’s disease.